Acetrizoic acid presents the molecular formula of 3-acetamidol-2,4,6-triiodobenzoic acid and it is the first monomeric ionic compound used as an X-ray contrast agent. It was first synthesized by Wallingford in... It was first synthesized by Wallingford in 1953 and it was filled in the FDA by the Johnson & Johnson subsidiary, Cilag Chemie AG, on February 8th, 1978.
- Mechanism
- Curator reviewed · 1 reference
Iodine, a big component in acetrizoic acid, is an element with a high atomic density. This property causes attenuation of X-rays within the diagnostic energy spectrum. Thus, acetrizoic acid is a water-soluble and reasonably safe iodinated contrast agent that can be intravenously administered for clinical applications.
- Primary indication
- Acetrizoic acid indication was to be used as a contrast agent for X-ray.Curator reviewed
- Formula / weight
- C9H6I3NO3 · 556.864 g/mol (avg)
- Also known as
- Urokonic acid
Resolves to
GNOGSFBXBWBTIG-UHFFFAOYSA-NSMILESCC(=O)NC1=C(I)C(C(O)=O)=C(I)C=C1IWhat you can answer from here — as of August 30, 2026
Which drugs share a target with Acetrizoic acid, and which of those have an active Phase 3 trial?
Create a free account or log in to explore the full data card.
Create Account